The Innovative FEED Act of 2025 creates a new regulatory category for "zootechnical animal food substances" - additives in animal feed that affect digestion, reduce foodborne pathogens, or alter gut microbiome without providing nutrition or treating disease. It requires manufacturers to submit specific data on intended effects and testing methods to the FDA for approval, rather than treating these substances as drugs. The bill mandates clear labeling stating "Not for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals" and defines what excludes substances (like hormones or drugs) from this category. This directly affects animal feed manufacturers, the FDA, and the regulatory process for these feed additives, without requiring their use.
The Ban Congressional Stock Trading Act (S 1879) requires current and new Members of Congress, along with their spouses and dependent children, to divest or place certain investments in qualified blind trusts. It defines "covered investments" broadly to include stocks, bonds, commodities, and derivatives, while excluding diversified mutual funds, Treasury securities, and retirement plan investments. Members must complete this process within 120 days of enacting the law (with possible 180-day extensions), and new members have 120 days after taking office to comply. The law mandates public reporting of assets placed in blind trusts and imposes civil penalties for non-compliance, equal to a monthly portion of the member's salary. This legislation directly affects congressional staff members and their immediate families who hold financial interests that could create conflicts of interest.
This bill expands workplace safety protections under the Occupational Safety and Health Act to cover public employees, including those working for federal, state, or local government agencies. It amends the law to explicitly include "the United States, a State, or a political subdivision of a State" in the definition of covered workers, removing previous exclusions. The key provision requires all public workplaces to follow OSHA safety standards, with a 36-month transition period for states or localities without their own OSHA-approved plans. This directly affects government workers like teachers, police, and sanitation staff who were previously excluded from federal OSHA coverage.
The Crime Victims Fund Stabilization Act of 2025 amends the law governing deposits into the Crime Victims Fund, adding two new sources: funds from declined criminal prosecutions (without conviction) and certain False Claims Act recoveries (from 2025 through 2030). It specifically excludes two types of False Claims Act funds from these deposits: payments to whistleblowers (qui tam plaintiffs) and reimbursements for government fraud damages. This bill directly affects the Crime Victims Fund, which provides support to victims of crime, and adjusts how federal agencies handle False Claims Act cases. The changes aim to modify the fund's funding sources without altering the False Claims Act itself.
The ETAP Act of 2025 establishes a new Energy Threat Analysis Program within the Department of Energy to enhance security for the U.S. energy sector. The program creates an Energy Threat Analysis Center (physical and virtual) to monitor threats, analyze risks, and share actionable security information between government agencies (like DHS and NSA) and energy companies through existing groups like the Electricity Information Sharing and Analysis Center. It requires annual reporting to Congress, authorizes $50 million for fiscal years 2025-2029, and terminates after 10 years. The bill directly affects energy infrastructure operators, federal agencies coordinating on energy security, and the Electricity Information Sharing and Analysis Center by mandating new threat-sharing protocols and collaboration mechanisms.
The Investing in All of America Act of 2025 modifies the Small Business Investment Act of 1958 to adjust leverage limits for Small Business Investment Companies (SBICs). It reduces the maximum leverage ratio from 300% to 200% and sets new dollar caps ($175 million for most SBICs, $350 million for commonly controlled groups), adjusted annually for inflation. The bill expands eligibility for favorable leverage treatment to include investments in rural areas, critical technology sectors, and small manufacturers. These changes directly affect SBICs that provide financing to small businesses, altering how they structure debt and private capital.
This bill amends the CDFI Bond Guarantee Program to improve its operation. It raises the minimum guarantee amount to $25 million per bond issue, sets an annual cap of $1 billion for all guarantees, and extends the program's deadline by four years from enactment. The changes aim to provide more predictable access to long-term capital for Community Development Financial Institutions (CDFIs) serving underserved communities. The bill also requires the Treasury Secretary to submit two reports on the program's effectiveness to Congress within one and three years of enactment.
This bill requires the Securities and Exchange Commission (SEC) to establish rules allowing financial firms (like investment companies, brokers, and advisers) to deliver regulatory documents electronically to investors. Covered entities must provide initial paper copies to investors not using electronic delivery, offer a 180-day transition period, and send annual paper reminders for two years about the option to opt out of electronic delivery. Investors can always choose paper versions, and firms must ensure electronic documents are secure, readable, and reliably delivered. The SEC must finalize these rules within one year of the bill's enactment, with firms permitted to use electronic delivery immediately if the SEC misses the deadline. This changes how investors receive financial disclosures but does not alter the content or timing of required documents.
The Vote at Home Act of 2025 would require all states to mail ballots to registered voters at least two weeks before federal elections, making voting by mail the default option for all eligible voters. It eliminates unnecessary barriers like notary requirements and excuse documentation for mail-in voting while ensuring ballots are accessible for people with disabilities. The bill also mandates free postage for election mail and expands automatic voter registration through motor vehicle departments. These changes would directly affect all voters participating in federal elections across the United States, aiming to increase accessibility and participation.
HRES 441 is a symbolic House resolution expressing support for designating May 2025 as "Mental Health Awareness Month." It does not create new laws, allocate funding, or change existing policies - it solely aims to raise public awareness about mental health challenges. The resolution cites statistics on rising mental health issues (including youth depression, suicide rates, and disparities in care access) to underscore the need for greater attention. It encourages the public, schools, and organizations to use the month to promote mental well-being and reduce stigma, but contains no concrete policy changes or mandates.
This bill requires candidates' committees and leadership PACs to disburse all leftover campaign funds within six months after an election. Committees must first cover operational costs, then return contributions or donate to certain tax-exempt charities - but cannot fund organizations created by the candidate, bearing their name, or run by them or family members. It also mandates that former candidates registering as lobbyists or foreign agents certify compliance with these disbursement rules. The law applies to elections starting with the 2026 general election.
The SMART Prices Act (S 1836) changes how Medicare negotiates drug prices. It increases the number of drugs eligible for negotiation from 15 to 50 per year starting in 2028, shortens the time drugs must be the sole source for eligibility from 7 to 3 years, and adjusts price ceiling percentages for negotiated drugs (e.g., raising the maximum fair price from 75% to 76% for some drugs). These changes directly affect Medicare Part D beneficiaries and pharmaceutical companies by altering the negotiation process and pricing caps. The bill modifies existing Medicare drug pricing rules without creating new programs, applying to initial price negotiations beginning in 2028.
